CLASS II Device recall · Reported 19 Aug 2020 · FDA Enforcement Report

Barricaid Annual Closure Device (ACD) BAR-A8 recalled

Intrinsic Therapeutics is recalling Barricaid Annual Closure Device (ACD) BAR-A8, distributed nationwide in the US. The recall was initiated on 24 Jul 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesCatalog #: BAR-A8-8MM Part #: 2730815-A8 Lot #: 06112001, 06152001
Quantity recalled110 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2798-2020
FDA event ID
86121
Recalling firm
Intrinsic Therapeutics, Woburn, MA
Classification
Class II
Status
Terminated
Recall initiated
24 Jul 2020
FDA classified
13 Aug 2020
Reported
19 Aug 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction
Device type
Spinal Implants

Timeline

24 Jul 2020Recall initiated by company
13 Aug 2020Classified by FDA+20 days
19 Aug 2020Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The catalog ( REF ) number on the peelable inner labels (patient sticker) that is on the inner container (box) is incorrect. It states BAR-A8-10MM instead of BAR-A8-8MM.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Barricaid Annual Closure Device (ACD) BAR-A8-8MM - Product Usage: The Barricaid¿ ACD is indicated for reducing the incidence of reherniation, and reoperation in skeletally mature patients with radiculopathy (with or without back pain) attributed to a posterior or posterolateral herniation, and confirmed by history, physical examination and imaging studies which demonstrate neural compression using MRI to treat a large annular defect (between 4-6 mm tall and between 6-10 mm wide) following a primary discectomy procedure (excision of herniated intervertebral disc) at a single level between L4 and S1.

Where it was distributed

US Nationwide distribution.

Nationwide

Questions about this recall

Why was it recalled?

The catalog ( REF ) number on the peelable inner labels (patient sticker) that is on the inner container (box) is incorrect. It states BAR-A8-10MM instead of BAR-A8-8MM.

Which lots are affected?

Catalog #: BAR-A8-8MM Part #: 2730815-A8 Lot #: 06112001, 06152001

Where was it sold?

US Nationwide distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Intrinsic Therapeutics

All 2
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IIBarricaid Annular Closure Impactor recalled by Intrinsic TherapeuticsIntrinsic TherapeuticsOtherNationwide

Other Spinal Implants recalls

All 1,157